EGFR amplification has been implicated in resistance to anti-EGFR therapies and may contribute to tumor proliferation, angiogenesis, and organotropism, potentially facilitating ocular dissemination via choroidal vasculature (Benli et al., 2025). Here, EGFR is linked to neoplasm.